Oxygen derived free radicals are considered to play an important part in the development of inflammation. A whole blood chemiluminescence assay was used to study N-formylmethionyl-leucyl-phenylalanine induced oxygen radical production in subjects with ankylosing spondylitis or previous yersinia arthritis. In luminol enhanced chemiluminescence, the subjects with previous yersinia arthritis showed significantly increased initial activation (at one minute), whereas the subjects with ankylosing spondylitis showed decreased responses at both the initial activation and at peak activation (at two to three minutes). This finding gives credence to the view that, in terms of oxygen radical production, the pathogenesis of yersinia arthritis is different from that of ankylosing spondylitis.
The pathogenesis of spondyloarthropathies is unknown, but both an aberrant immune response' and inappropriate inflammatory hyperreactivity9 may be involved. Patients with yersinia arthritis have altered cell mediated and humoral immunity against yersinia.'0 " Serum samples from patients with acute yersinia arthritis have a stronger opsonic capacity than serum samples from patients with non complicated yersiniosis. 12 The initial activation, but neither the peak response nor the area under the curve, in N-formyl-methionyl-leucylphenylalanine (fMLP) induced luminol enhanced whole blood chemiluminescence is increased in subjects with previous yersinia arthritis. '3 In patients with previous yersinia arthritis the increased oxygen radical production from purified neutrophils is associated with the severity of the acute disease'4 and the presence of sequelae,15 whereas in ankylosing spondylitis the neutrophil oxygen radical production is reported to be normal'6 or decreased. 17 The exact role of oxygen radicals in the inflammatory damage of arthritides is not known. 8 The purpose of this work was to study oxygen radical production in patients with previous yersinia arthritis who had experienced severe or mild acute disease, with or without sequelae, in patients with ankylosing spondylitis, and in healthy subjects who were HLA-B27 positive or negative. Luminol and lucigenin enhanced responses were determined; the former measures mainly the reaction between hydrogen peroxide and myeloperoxidase,19 whereas the latter measures mainly superoxide production.20
Patients and methods
PATIENTS
Twenty five HLA-B27 positive or negative subjects were selected from a follow up study group of patients with yersinia arthritis.2' The diagnosis of yersinia arthritis was based on the typical clinical symptoms of reactive arthritis22 and a raised agglutination antibody titre (>1/160) for Yersinia enterocolitica (0:3 or 0:9), or a stool culture positive for the organism. The patients with previous yersinia arthritis were grouped according to the HLA-B27 antigen, the clinical features of acute disease, and the presence of sequelae (radiological sacroiliitis, enthesopathies, or iritis) during follow up (table  1) . Seven HLA-B27 positive subjects with ankylosing spondylitis, who fulfilled the New York criteria for definite ankylosing spondylitis23 and who had had predominantly axial inflammation, were selected from patients at the outpatient clinic of the second department of for three minutes and the peak response, recorded in millivolts, was calculated from the curve obtained. The arithmetic mean of triplicate measurements was calculated and then converted to be equivalent to the chemiluminescence response of 2-5x109 neutrophils per litre in 135 g/l haemoglobin with a correction factor based on both the neutrophil count and the haemoglobin concentration. 24 The correction factor is based on an experimental study with cell mixtures24 in which the correlation of the neutrophil count with chemiluminescence was positive and linear, whereas the correlation of the haemoglobin concentration with chemiluminescence was negative and linearity was attained by logarithmic transformation. The corrected chemiluminescence values are presented.
STATISTICS
The significance of the difference between the groups was evaluated by the analysis of variance; we evaluated the effect of (1) previous yersinia arthritis and HLA-B27 among subjects with previous yersinia arthritis and healthy subjects; (2) clinical features among subjects with previous yersinia arthritis; (3) ankylosing spondylitis among subjects with ankylosing spondylitis and healthy subjects; and (4) type of spondyloarthropathy among HLA-B27 positive subjects who had ankylosing spondylitis, had had yersinia arthritis, or who were healthy. The significance of the difference between the subgroups with different clinical features of previous yersinia arthritis was evaluated by the Mann-Whitney U test. On the basis of the analysis of the frequency distributions of all the parameters measured, logarithmic transformation of the data was performed before the analysis of variance and the geometric mean and standard error of the mean were used in the presentation of the data.
Results

YERSINIA ARTHRITIS AND THE HLA-B27 ANTIGEN
The subjects with previous yersinia arthritis (n=25) had higher responses than the healthy subjects (n=20) for all the parameters analysed, except in the phosphate buffered saline induced one minute responses (table 2); the association fig 2A) . When the effect of the presence of the HLA-B27 antigen was analysed in subjects with yersinia arthritis and healthy subjects the effect of the presence of HLA-B27 was not statistically significant (table 3) . However, the healthy subjects with HLA-B27 (n= 10) had higher responses than those without HLA-B27 (n= 10) (table 2), although the difference was not statistically significant.
CLINICAL FEATURES OF YERSINIA ARTHRITIS
The subjects who with previous severe yersinia arthritis (n= 12) showed higher responses in all the parameters analysed than those who with previous mild yersinia arthritis ( subgroup with mild arthritis with sequelae present and the subgroup with mild arthritis with sequelae absent was significant (p<0O05; The opposite types of aberrations in oxygen radical production may reflect differences in the pathogenesis of yersinia arthritis and ankylosing spondylitis. Yersinia arthritis is characterised by an acute onset after an enteric infection, whereas ankylosing spondylitis develops insidiously without an obvious triggering infection.' Interestingly, in this study the subjects with previous yersinia arthritis who had had mild acute arthritis and sequelae during the follow up, with a clinical picture resembling that ofankylosing spondylitis, had low responses in the peak values of fMLP induced luminol enhanced chemiluminescence in a similar manner to the subjects with ankylosing spondylitis.
The pathogenesis of spondyloarthropathies is probably multifactorial35 and may involve aberrations in humoral and cellular immunity9-'2 36 37 and increased permeability of the gut.38 39 The results of this study indicate that oxygen radical production from stimulated neutrophils, tested here concurrently, is increased in subjects with previous yersinia arthritis and decreased in subjects with ankylosing spondylitis. The mechanisms underlying these aberrations and whether the aberrations have different roles in the pathogenesis ofseronegative spondyloarthropathies remain to be studied. 
